In solid-phase assembly of host-defense peptides containing a D-methionine residue at the N-terminal flank or within the hydrophobic face, Fmoc-D-methionine is coupled after Fmoc deprotection of the preceding L-amino acid using an automated microwave synthesizer operating at 75 °C for 5 min in DMF with 0.5 M HATU and N,N-diisopropylethylamine at a final ratio of 4 equiv Fmoc-D-Met-OH, 4 equiv HATU, and 8 equiv DIPEA relative to Rink amide AM resin substitution 0.47 mmol/g. The steric bulk of the D-methionine α-carbon slows acylation when the following residue is β-branched Fmoc-D-Ile or Fmoc-D-Val; in these positions a single 5 min coupling cycle can leave unreacted amino groups that later produce deletion peptides. Typical correction is a second coupling at 75 °C for 5 min with fresh Fmoc-D-Met-OH (3 equiv), HATU (3 equiv), and DIPEA (6 equiv). Fmoc removal uses 20% piperidine in DMF in two stages of 10 min at 25 °C under nitrogen agitation at 30 rpm; incomplete deprotection after the first stage is monitored by bromophenol blue or by conductivity feed-back on the synthesizer. Final side-chain deprotection and cleavage from the resin requires TFA/TIS/H₂O 95:2.5:2.5 v/v/v for 2.5 h at 25 °C, followed by precipitation in cold methyl tert-butyl ether at -20 °C. The resulting peptide is analyzed on a C18 column 250 mm × 4.6 mm, 5 µm, with a gradient from 5% to 60% acetonitrile in 0.1% TFA over 30 min at 1 mL/min. Production-scale batch records show that deletion peptide peak at approximately 2.7 min earlier retention time on this gradient originates from single-coupling failure specifically at D-Met sites, not from piperidine exposure. The thioether side chain of D-methionine introduces a second process limit: it can be alkylated or oxidized during cleavage if the scavenger ratio is reduced below 2.5% triisopropylsilane. This first application therefore requires both steric double-coupling control and methionine-specific cleavage management.

When peptide drug candidates require stabilization against aminopeptidases and serum serine proteases, substitution of an L-Met residue with D-Met via Fmoc-D-methionine introduces an inversion at the α-carbon that impedes recognition by proteolytic active sites while retaining the side-chain thioether geometry and hydrophobicity. On a 1.2 mmol/g 2-chlorotrityl chloride resin, Fmoc-D-methionine is anchored through its carboxyl terminus using 1.5 equiv Fmoc-D-Met-OH and 4 equiv DIPEA in dichloromethane for 2 h at 25 °C, then capped with methanol/DIPEA 4:1 v/v for 30 min to block unreacted chloride sites. Subsequent chain elongation may use either Fmoc/HATU or Fmoc/DIC/Oxyma cycles; the latter is preferred because D-Met placement near the C-terminal ester can be sensitive to prolonged storage on resin under basic conditions. The D-Met residue is placed at P1 or P1′ of scissile bonds in peptidic antagonists or receptor ligands where plasma stability is critical. The half-life gain is sequence-dependent; published data for specific D-Met substitution in peptide drug candidates is limited, and screening of multiple positions is required before lead selection. Methionine oxidation remains the principal degradation route, converting the thioether to methionine sulfoxide during acidic cleavage, lyophilization, or long-term storage at ambient temperature. For peptide acids, cleavage from 2-chlorotrityl resin uses 20% hexafluoroisopropanol in dichloromethane for 30 min, avoiding TFA-induced sulfoxide formation. The resulting peptide is purified by preparative HPLC on a C18 column 250 mm × 21.2 mm, 10 µm, with a linear gradient of acetonitrile in 0.1% TFA or 0.1% acetic acid. ESI-MS in positive mode confirms the product mass; an additional +16 Da peak corresponds to methionine sulfoxide and must be controlled below 1.0 area% in the final product for early-stage pharmacology studies. The D-Met containing peptide is lyophilized from 0.1% aqueous acetic acid at shelf temperature -40 °C for 24 h to limit oxidation.

What Limits Methionine Oxidation During TFA-Mediated Cleavage of D-Met Peptides?

During the final acidic cleavage of a D-Met-containing peptide from Rink or Wang resin, the thioether side chain is exposed to reactive carbocations generated from tert-butyl, trityl, and Boc groups released into the cleavage mixture. Without sufficient scavenger, the sulfur atom attacks tert-butyl cations to form a sulfonium species, and dissolved oxygen or prolonged acid contact converts the thioether to methionine sulfoxide. The cleavage cocktail must therefore include triisopropylsilane at 2.5% v/v and, where the peptide sequence tolerates it, thioanisole at 2.5% v/v in TFA; water at 2.5% v/v is retained as a weak nucleophile to trap residual carbocations. Temperature is controlled at 25 °C because the pseudo-first-order methionine oxidation rate increases sharply above 30 °C during the 2–3 h cleavage window. After filtration, the crude peptide is precipitated in cold MTBE at -20 °C, and the ether supernate is checked by RP-HPLC for the late-eluting Fmoc-protected intermediate. If the D-Met-containing peptide already contains methionine sulfoxide due to air exposure, a reduction step can be performed with ammonium iodide in TFA/dimethyl sulfide at 0 °C for 15–30 min; this conversion is monitored by the disappearance of the +16 Da mass peak and a shift in RP-HPLC retention time to the reduced thioether peak. Analytical method transfer to QC uses Ph. Eur. 2.2.29 and USP 621 liquid chromatography; equilibration of the C18 column with 0.1% TFA mobile phase avoids peak tailing caused by the ionizable N-terminus of crude peptides. The operational boundary is clear: scavenger concentration below 2.0% triisopropylsilane leads to observable methionine sulfoxide formation in TFA-cleaved peptides after 2 h, while excess thioanisole above 5% can complicate downstream extraction with MTBE and leave an odorous residual solvent that requires additional lyophilization cycles.

In macrocyclic peptide synthesis where D-methionine occupies a hydrophobic contact face, Fmoc-D-methionine is used to introduce the D-configuration before on-resin or off-resin cyclization. A typical route assembles the linear sequence on 2-chlorotrityl chloride resin, with Fmoc-D-Met-OH coupled at the position intended to sit at the hydrophobic interface between the peptide ring and a target protein binding pocket. After chain elongation, the linear side-chain-protected peptide is cleaved with 20% hexafluoroisopropanol in dichloromethane for 30 min at 25 °C, neutralized with DIPEA, and cyclized in dilute DMF at 1 mM peptide concentration using HATU (3 equiv) and DIPEA (6 equiv) for 2 h. D-Met itself is not typically used as the macrocyclization point because its side chain lacks a compatible functional group; rather, the D-configuration influences ring closure yields by altering backbone dihedral angles and reducing aggregation of the linear precursor. Reactions are monitored by analytical HPLC and mass spectrometry; the cyclic product generally elutes earlier than the linear precursor under reversed-phase conditions. If the D-Met thioether is oxidized under the cyclization atmosphere, the resulting methionine sulfoxide changes the hydrophobicity of the hydrophobic contact face and can reduce biological activity; therefore, cyclization is performed under nitrogen and the solvent is degassed by argon sparging for 10 min before use. Published data for specific macrocyclization yields with D-Met at the turn position is limited; sequence-dependent screening is required because a single D-Met residue can either improve or disrupt the cyclic scaffold depending on ring size and adjacent β-branched residues. Analytical characterization includes circular dichroism to compare the D-Met-containing cyclic peptide with its all-L analog, but CD spectral interpretation is limited by the thioether chromophore and requires concentration validation at 0.1 mg/mL in 10 mM phosphate buffer pH 7.4.

When D-Met Thioether Hydration Governs Peptide Hydrogel Storage Modulus

Hydrogel formulations assembled from Fmoc-protected diphenylalanine or related peptidomimetic gelators can incorporate Fmoc-D-methionine as a co-monomer to tune the hydrophobic network through the thioether side chain while the D-configuration reduces enzymatic degradation in cell culture conditions. The Fmoc protecting group remains intact after SPPS-type assembly if the hydrogelator is prepared from Fmoc-amino acid building blocks rather than deprotected peptide, and the gel is formed by solvent switching from dimethyl sulfoxide to water at pH 7.4 with phosphate-buffered saline. The critical gelation concentration is system-specific; published data for Fmoc-D-Met homodipeptide gelation is limited, and empirical determination with a 20 mm parallel-plate oscillatory rheometer at 1 Hz and 0.1% strain is necessary. A stable hydrogel is typically identified when the storage modulus G′ exceeds the loss modulus G″ by at least one order of magnitude after 24 h annealing at 25 °C. The thioether in D-Met is less polar than the sulfoxide analog and does not participate in strong hydrogen bonding, so gel stiffness may be lower than an otherwise identical peptide containing methionine sulfoxide; conversely, the D-configuration suppresses matrix metalloproteinase cleavage and prolongs scaffold persistence in serum-containing media. Process incompatibilities include high salt concentrations above 150 mM sodium chloride, which can precipitate the Fmoc-protected building block before gelation, and residual DMSO above 5% v/v, which disrupts hydrophobic assembly. Fmoc-D-methionine is first dissolved in dimethyl sulfoxide at 100 mM, then diluted into the aqueous phase to the target final concentration under gentle vortexing; the mixture is heated to 60 °C for 10 min and allowed to cool. This thermal treatment reverses kinetically trapped aggregates and improves batch-to-batch reproducibility of the storage modulus measured after 4 h at 25 °C.

Epimerization-Free Coupling of Fmoc-D-Methionine in Multigram Campaigns

Scale-up of D-Met-containing peptide APIs from 0.1 mmol discovery scale to 10–50 mmol multigram campaigns requires revalidation of coupling conditions because the longer activation times and larger reactor volumes can promote α-carbon epimerization at D-Met. Fmoc-D-methionine is typically dissolved in DMF at 0.2 M; residual particulate is removed by filtration through a 0.45 µm PTFE membrane to avoid uneven delivery into 250 mL or 1 L fritted glass solid-phase reactors. Coupling with DIC/Oxyma in NMP at 4 equiv Fmoc-D-Met-OH, 4 equiv DIC, and 4 equiv Oxyma relative to resin free amine at 25 °C for 60 min gives lower epimerization risk than HATU/DIPEA at room temperature because the uronium reagent can deprotonate the α-carbon under prolonged exposure. However, DIC/Oxyma cycles are slower, so production schedules use two consecutive couplings for D-Met at sterically hindered positions. In-process control includes Kaiser ninhydrin tests after each D-Met coupling; residual free amino groups indicate incomplete acylation and require a third coupling with 3 equiv of the protected amino acid. The final peptide is analyzed for D/L epimer content by chiral amino acid hydrolysis and Marfey's derivatization with N-α-(2,4-dinitro-5-fluorophenyl)-L-alaninamide; the D-Met content is measured against a standard of Fmoc-D-Met-OH after acid hydrolysis in 6 M hydrochloric acid at 110 °C for 24 h. Methionine can be partially oxidized during acid hydrolysis, so methionine sulfoxide is quantified separately and the sum of Met and Met(O) is used for enantiomeric ratio. The acceptance criterion for D-Met-containing peptide APIs under early-phase development is generally ≥99.0 area% HPLC purity and ≥99.5% enantiomeric purity for the D-Met residue. Residual solvent levels follow ICH Q3C: DMF ≤ 880 ppm, dichloromethane ≤ 600 ppm, MTBE ≤ 5000 ppm. In a 1 L fritted glass reactor with overhead stirring at 80 rpm, the main production-scale failure is diffusion-limited coupling in the center of the packed resin bed; this is corrected by periodic nitrogen backflush and by increasing the coupling time from 30 min to 60 min for positions immediately after D-Met.

Production of peptide-based diagnostic probes labelled with chelators for gallium-68 or copper-64 often includes Fmoc-D-methionine to prolong metabolic half-life in vivo while retaining a thioether side chain that may be oxidized to methionine sulfoxide under radiolabeling conditions. In these sequences the D-Met residue is positioned at the N-terminus or immediately after the chelator-conjugated lysine to reduce exopeptidase cleavage without altering the metal-binding site. The peptide is assembled on Rink amide AM resin as described, with Fmoc-D-methionine coupled at the chosen position using HATU/DIPEA at 75 °C for 5 min. After cleavage and purification, the chelator is conjugated on-resin or solution-phase; DOTA or NOTA conjugation to the ε-amino group of a lysine side chain is performed with DOTA-NHS-ester in NMP at pH 8.0–8.5 for 2 h at 25 °C. The D-Met thioether imposes a thermal boundary during radiolabeling: gallium-68 labeling at 95 °C for 10 min can increase methionine sulfoxide formation, so the reaction is cooled immediately after heating and quenched with 0.1 M sodium acetate buffer pH 4.5. Radiochemical purity is assessed by instant thin-layer chromatography and radio-HPLC using a C18 column with a gamma detector; the product peak is identified by co-injection with the non-radioactive standard. D-Met confers proteolytic resistance but not oxidative stability, and formulation buffers containing ascorbic acid or methionine as sacrificial antioxidant are used to limit radiolytic oxidation during storage. Acceptance criteria for the final diagnostic precursor are based on USP 823 radiolabeling and Ph. Eur. 2.2.29 liquid chromatography; the precursor should have ≥99.0 area% HPLC purity and a single enantiomer peak for the D-Met residue. The operational boundary is that gallium-68 labeling pH below 3.0 accelerates thioether protonation and decomposition, while pH above 5.5 reduces chelation kinetics.

Protease Substrate Libraries with Non-Proteinogenic Stereochemistry

Peptide libraries used to profile protease substrate specificity in complex biological matrices frequently include Fmoc-D-methionine at P1 or P1′ to generate background-cleavage-resistant substrates. A representative FRET substrate is assembled from a C-terminal fluorophore/acceptor quencher pair on 2-chlorotrityl chloride resin, with Fmoc-D-Met coupled at the recognition site and the remainder of the sequence composed of L-amino acids. The D-Met building block is activated with DIC/Oxyma in NMP at 4 equiv, 25 °C, 45 min to minimize epimerization; the N-terminal Fmoc is removed and the peptide is capped with acetic anhydride/pyridine 1:1 v/v before resin cleavage. The quencher, often a lysine side-chain coupled acceptor, is introduced after the D-Met coupling so that the FRET pair reports cleavage at the adjacent amide bond. Cleavage from 2-chlorotrityl resin uses 20% hexafluoroisopropanol in dichloromethane, and the peptide is precipitated in cold ether. Enzymatic assays are run in 50 mM HEPES buffer pH 7.4 containing 10 mM calcium chloride and 0.01% Tween-20, with substrate concentrations typically 10 µM. Fluorescence is recorded at 350 nm excitation and 470 nm emission in a plate reader, and initial velocities are fitted to the Michaelis-Menten equation. The D-Met residue prevents cleavage by contaminating serum proteases but may also reduce the turnover rate of the target protease if the enzyme has strict L-amino acid specificity; thus D-Met-containing substrates are used as background controls alongside L-Met substrates. No universal acceptance criterion exists for such libraries; each substrate lot is qualified by HPLC purity ≥95 area% under Ph. Eur. 2.2.29 and by a signal-to-background ratio of at least 10:1 at 60 min incubation with active protease versus heat-inactivated control. The thioether side chain remains sensitive to oxidation during storage; substrate stock solutions are aliquoted under argon and kept at -20 °C for no longer than 30 days to maintain fluorescence assay reproducibility.